Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

New mechanism of action of AN-3365 linked to potent activity in Gram-negative bacterial infections

Oct. 6, 2010

Maximum tolerated dose of ARRY-380 established in patients with breast cancer

Oct. 5, 2010

Phase I data support safety of TissueGene-C in osteoarthritis

Oct. 5, 2010

Intranasal XF-73 well tolerated in phase I study

Oct. 5, 2010

Preclinical and clinical data reported on neoglycoside ACHN-490

Oct. 5, 2010

PH-797804 improves lung function in patients with COPD

Oct. 5, 2010

MedImmune reports clinical data on asthma candidates MEDI-563 and MEDI-528

Oct. 5, 2010

Phase II trial of IMA-901 shows benefit of cyclophosphamide pretreatment

Oct. 4, 2010

NNC-126-0083 is well tolerated in adults and children with growth hormone deficiency

Oct. 4, 2010

Phase I investigation of CombiHIVvac HIV vaccine begins

Oct. 4, 2010

Popular Stories

Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...
Innervation can slow, as well as speed, tumor growth, study finds
BioWorld
Innervation by the sympathetic nervous system is typically a boon to tumors. But researchers from Weill Cornell Medicine and colleagues have shown that in some...